A cancer trial published in the New England Journal of Medicine on June 5, 2022 is the first ever to report the removal of the disease in every single patient. Twelve rectal cancer patients were given dostarlimab (Jemperli), a monoclonal antibody, every 3 weeks for 6 months. Doctors could not find any evidence of tumors after treatment; patients continued to show no signs of cancer during check-ups ranging in the subsequent 6-25 month period. No surgery, radiation or chemotherapy was ever administered. No adverse events of grade 3 or higher were ever reported. 

Refined salt was created in the early 1900s. However, a serious problem soon manifested itself as a result. Developers used extensive chemical processing to remove everything besides pure sodium and chloride. All of the 60+ naturally occurring minerals were removed as impurities. No one understood at the time the significant role minerals played in human health. The developers were only interested in removing the other mineral compounds so they could create a salt that did not clump in humid conditions. The public loved it because it would pour out of salt shakers without getting stuck in the container. Unfortunately, a huge health condition problem soon developed which required the government to intervene and legislate the addition of one of those important missing minerals.  ​

A French study strongly suggests a link between COVID vaccines and a fatal brain disease known as Creutzfeldt-Jakob Disease (CJD). Symptoms appear on average 11 days after the first or second dose injection. Of the 26 cases reviewed, 20 individuals had died by the time the study was published (in less than 5 months' time) and the last 6 shortly thereafter. CJD is a degenerative brain disorder that leads to dementia and death. CJD is a prion disease. These diseases are progressive neurodegenerative disorders affecting humans and animals (remember Mad Cow Disease?). Abnormal misfolding of prion glycoproteins leads to brain damage. Once a single prion becomes infected, it progresses to other prion glycoproteins and there is no treatment capable of stopping it.  

The Food and Drug Administration (FDA) bestowed Emergency Use Authorization (EUA) on the latest COVID-19 vaccine, Novavax. Novavax is touted as a more traditional vaccine and health officials hope that it will sway the unvaccinated to get this safe injection. The two-dose series of shots targets the original Wuhan SARS-CoV-2 virus (not any of the recent variants) and is available only for adults 18 years of age and over. About two-thirds of Americans already have received a Pfizer, Moderna, or Johnson & Johnson initial series of shots. Novavax is available in other countries under the name Nuvaxovid.